New initiative aims to help tens of thousands with recurrent pericarditis [Yahoo! Finance]
Kiniksa Pharmaceuticals, Ltd. - Class A (KNSA)
Last kiniksa pharmaceuticals, ltd. - class a earnings: 8/12 04:02 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
structure that protects the heart, which can cause chest pain and may lead to fluid buildup around the heart muscle. The American Heart Association, celebrating 100 years of lifesaving service in 2024, is launching a three-year initiative to empower patients and equip health care providers with up-to-date science to inform recurrent pericarditis care decisions. The Addressing Recurrent Pericarditis initiative , supported by Kiniksa Pharmaceuticals, aims to improve diagnosis, treatment and quality of life for those with the disease by: addressing gaps and barriers in patient care, educating health care professionals, and developing tailored patient education resources. "Recurrent pericarditis symptoms can have significant impact on emotional health and quality of life, but they often go undiagnosed and untreated," said Mariell Jessup, M.D., FAHA, chief science and medical officer of the American Heart Association. "This new initiative will share insights and best practices
Show less
Read more
Impact Snapshot
Event Time:
KNSA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KNSA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KNSA alerts
High impacting Kiniksa Pharmaceuticals, Ltd. - Class A news events
Weekly update
A roundup of the hottest topics
KNSA
News
- Kiniksa Pharmaceuticals Partners with NHL Hall-of-Famer Henrik Lundqvist to Raise Awareness of Recurrent Pericarditis [Yahoo! Finance]Yahoo! Finance
- Kiniksa Pharmaceuticals Partners with NHL Hall-of-Famer Henrik Lundqvist to Raise Awareness of Recurrent PericarditisGlobeNewswire
- Kiniksa Pharmaceuticals Sponsors American Heart Association's Addressing Recurrent Pericarditis Initiative [Yahoo! Finance]Yahoo! Finance
- Kiniksa Pharmaceuticals Sponsors American Heart Association’s Addressing Recurrent Pericarditis InitiativeGlobeNewswire
- Kiniksa Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare ConferenceGlobeNewswire
KNSA
Earnings
- 4/23/24 - Miss
KNSA
Sec Filings
- 6/25/24 - Form 8-K
- 6/14/24 - Form 8-K
- 6/7/24 - Form 4
- KNSA's page on the SEC website